Empresa
Sobre Nosotros
Nuestro Equipo
Descubrimientos
Programas
Publicaciones
Seleccionadas
Todas
EN
Contacto
Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean
Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean
Galectin-1 Cooperates with Yersinia Outer Protein (Yop) P to Thwart Protective Immunity by Repressing Nitric Oxide Production
Galectins
L-Type Lectins
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
Galectins in Chagas Disease: A Missing Link Between Trypanosoma cruzi Infection, Inflammation, and Tissue Damage
Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression
Galectins as potential therapeutic targets in STIs in the female genital tract
Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm
Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis
